This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Castro-Gago, M. Articles by Eirís-Puñal, J. Search for Related Content PubMed PubMed Citation Articles by Castro-Gago, M. Articles by Eirís-Puñal, J. Social Bookmarking                         What's this?

Evolution of Serum Lipids and Lipoprotein (a) Levels in Epileptic Children Treated With Carbamazepine, Valproic Acid, and Phenobarbital

Servicio de Laboratorio Central,, Departamento de Pediatría, Servicio de Neuropediatría, Hospital Clínico-Universitario, Universidad de Santiago de Compostela, Santiago de Compostela, Spain, pdcastro{at}usc.es

María Inés Novo-Rodríguez, MD

Departamento de Pediatría, Servicio de Neuropediatría, Hospital Clínico-Universitario, Universidad de Santiago de Compostela, Santiago de Compostela, Spain

Manuel Oscar Blanco-Barca, MD

Departamento de Pediatría, Servicio de Neuropediatría, Hospital Clínico-Universitario, Universidad de Santiago de Compostela, Santiago de Compostela, Spain

Adela Urisarri-Ruíz de Cortázar, MD

Departamento de Pediatría, Servicio de Neuropediatría, Hospital Clínico-Universitario, Universidad de Santiago de Compostela, Santiago de Compostela, Spain

Javier Rodríguez-García, PhD

Hospital Clínico-Universitario, Universidad de Santiago de Compostela, Santiago de Compostela, Spain

Santiago Rodríguez-Segade, PhD

Hospital Clínico-Universitario, Universidad de Santiago de Compostela, Santiago de Compostela, Spain

Jesús Eirís-Puñal, MD

Departamento de Pediatría, Servicio de Neuropediatría, Hospital Clínico-Universitario, Universidad de Santiago de Compostela, Santiago de Compostela, Spain

The concentration levels of serum lipids and lipoprotein (a) were measured in 20 children receiving carbamazepine, 25 children receiving valproic acid, and 5 children receiving phenobarbital at the following times: (1) during chronic treatment while eating a normal diet, (2) during chronic treatment while eating a low-fat diet (children treated with carbamazepine and phenobarbital with high levels of total choleserol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol), and (3) 3 months after the end of treatment with antiepileptic drugs. Patients during chronic treatment and eating a normal diet revealed significant changes in lipids, but when we reevaluated the groups of children treated with carbamazepine and phenobarbital when they were eating a low-fat diet and reevaluated the three groups of children 3 months after the end of treatment, a complete return to normal of all parameters was observed. These data demonstrate that the changes induced by these drugs are transient, reversible, and influenced by a low-fat diet. (J Child Neurol 2006;21:48—53).

Journal of Child Neurology, Vol. 21, No. 1, 48-53 (2006)
DOI: 10.1177/08830738060210011601


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Castro-Gago and J. Eiris-Punal Correspondence on ``Lipid Profile, Apolipoproteins A and B in Children With Epilepsy'' J Child Neurol, April 1, 2009; 24(4): 515 - 516. [PDF]

				S. Grosso, R. Mostardini, B. Piccini, and P. Balestri Body Mass Index and Serum Lipid Changes During Treatment with Valproic Acid in Children with Epilepsy Ann. Pharmacother., January 1, 2009; 43(1): 45 - 50. [Abstract] [Full Text] [PDF]